Homegrown private equity firm Everstone Capital Group has made a significant investment in exchange for a stake in Translumina Therapeutics, a maker and distributor of cardiac stents and cardiovascular medical devices, the firm announced on Wednesday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
